Background and Purpose-In a geographically defined population, we assessed incidence and determinants of aphasia attributable to first-ever ischemic stroke (FEIS). MethodsA 1-year prospective, population-based study among the permanent residents of the canton Basle City, Switzerland, was performed using multiple overlapping sources of information. Results-Among 188 015 inhabitants, 269 patients had FEIS, of whom 80 (30%; 95% CI, 24 to 36) had aphasia. The overall incidence rate of aphasia attributable to FEIS amounted to 43 per 100 000 inhabitants (95% CI, 33 to 52). Aphasic stroke patients were older than nonaphasic patients. The risk of aphasia attributable to FEIS increased by 4% (95% CI, 1% to 7%), and after controlling for atrial fibrillation, by 3% (95% CI, 1% to 7%) with each year of patients' age. Gender had no effect on incidence, severity, or fluency of aphasia. Cardioembolism was more frequent in aphasic stroke patients than in nonaphasic ones (odds ratio [OR], 1.85; 95% CI, 1.07 to 3.20). Aphasic patients sought medical help earlier than nonaphasic stroke patients. Still, after controlling for stroke onset-assessment interval, aphasic stroke patients were more likely to receive thrombolysis than nonaphasics (OR, 3.5; 95% CI, 1.12 to 10.96). Conclusion-Annually, 43 of 100 000 inhabitants had aphasia resulting from first ischemic stroke. Advancing age and cardioembolism were associated with an increased risk for aphasia. Severity and fluency of aphasia were not affected by demographic variables.
A phasia in stroke patients is associated with increased mortality, 1 decreased rates of functional recovery, 2, 3 and reduced probability to return to work 4 compared with nonaphasic stroke patients. High-intensity speech therapy has been shown recently to improve outcome 5 but requires the availability of a sufficient number of qualified therapists. Thus, for planning stroke rehabilitation processes and resource allocation, epidemiological data about frequency and severity of aphasia in stroke patients are crucial. The frequency of aphasics among stroke patients ranged from 21% to 38%. 6 -10 However, these numbers are based on studies with different methodological approaches entailing specific limitations. Some used a retrospective design. 11 Some were based on surveys, 7 in-hospital stroke registries, 9 stroke unit cohorts, 1, 12 or patients of neurological departments. 10, 13 Most of these studies assessed only patients admitted to a hospital, 1, 6, 9, 12, 14 thus introducing a potential bias because the presence of aphasic symptoms may increase the probability of admission. 7, 15 Furthermore, aphasia studies meeting current standards for epidemiological studies 16 are lacking to the best of our knowledge.
Some groups reported that demographic factors like age and gender influence the occurrence, 10, 17 severity, 18 and fluency 9, 18, 19 of aphasia, whereas other studies could not confirm these findings. 6,20 -22 Aphasia was predominantly attributed to cardioembolic stroke etiology, 23 whereas other case series reported multiple underlying stroke mechanisms. 24 Population-based studies about stroke etiology stratified to the presence or absence of aphasia are lacking. Furthermore, it had yet to be studied whether there is an association between aphasia as stroke symptom and treatment with thrombolysis. With these considerations in mind, we designed a 1-year prospective, population-based study to determine the incidence and the determinants of aphasia resulting from first-ever ischemic stroke (FEIS), including an adjustment to European standard population. 25 designed a prospective bipartite study about the epidemiology of: FEIS 26 and of aphasia attributable to FEIS. The canton Basle City, Switzerland, was considered an appropriate model for such a study because of its geographically well-defined catchment area and the advanced degree of organized stroke care available for all inhabitants. After ethical approval, we prospectively recorded all FEIS patients among the residents of the canton Basle City in between  June 1, 2002, and May 31, 2003 (188 015 inhabitants, census 2002) .
Multiple, overlapping sources of information were used, as suggested by Sudlow and Warlow 16 (1) . The stroke register of the local university hospital, which is the only hospital providing stroke unit care not only in Basle City but in the whole region, enabled us to ascertain all stroke patients on a daily basis (2) . The register of the only neurorehabilitation unit of Basle City, which is located outside the university hospital, was used to identify all patients with in-hospital neurorehabilitation, regardless of the place of acute stroke treatment (3) . The records of speech therapists within all hospitals in Basle City were used to identify all stroke patients with aphasia (4). All hospitals in Basle City received mailings every 3 months to provide data about their stroke patients treated (5) . All physicians practicing in Basle City, taking care of nursing home residents, or filling in death certificates were contacted by mail every 3 months, to report on all stroke patients they have encountered. This approach was chosen to retrieve patients who were managed outside hospitals or who died because of stroke before hospitalization (6) . The records of a stroke neurologist who made stroke ward rounds in a nearby hospital outside Basle City were checked on a weekly basis for possible study patients (7) . For identification of pediatric strokes, the only pediatric hospital was contacted. The distribution of data sources and the manner in which our study population was assembled are shown in the Figure. 
Diagnosis and Assessment of Aphasia
In all stroke patients hospitalized in the university hospital, the diagnosis of aphasia was made by a stroke unit neurologist on admission. A bedside language examination 27 was done. It includes the use of the standardized items for language testing of the National Institutes of Health Stroke Scale, 28 which have a good inter-rater reliability ( value 0.68 to 0.71). 28 Additionally, within the next 3 days, evaluation by a speech therapist started in all patients with abnormalities of speech, language, or swallowing, and the BaselMinnesota Test for the differential diagnosis of aphasia 29, 30 was applied by the speech therapist to confirm or disapprove of the diagnosis of aphasia. In cases of disagreement between initial neurologist ratings and speech therapist assessments, consensus was reached by comparing the source data of both raters.
In patients hospitalized in primary care hospitals lacking stroke unit treatment, diagnosis of aphasia was made by a speech therapist. In patients not hospitalized, presence or absence of aphasia relied on the assessment of the treating primary care physician and a speech therapist, if such a therapy was implemented.
Patients with pre-existing aphasia caused by a nonstroke etiology were excluded, as were all patients who had aphasia resulting from ischemic stroke but in whom this event was a recurrent rather than the first ischemic stroke (nϭ9). Native languages other than German were no exclusion criterion.
Severity of aphasia was graded into 3 categories (ie, 1 mild, 2 moderate, and 3 severe) applying the aphasia subscale of the Scandinavian Stroke Scale. 31 This scale was used in a previous community-based aphasia study 6 and was shown to have a high inter-rater reliability ( value 0.86). Aphasia was dichotomized as fluent or nonfluent aphasia based on the initial bedside language assessment. 27 In cases of Ͼ1 severity or fluency ratings, the earliest assessment was used for further analysis.
Verification of Diagnosis and Determination of Stroke Etiology
Diagnoses "FEIS" and "aphasia" were verified by a single, experienced stroke neurologist (S.T.E.), who reviewed all available source data of reported patients. Source data check was performed for all patients who were either treated in the university hospital or in the rehabilitation unit, or both, and in selected cases for those assessed or treated elsewhere. For nonhospitalized patients, diagnoses of FEIS and aphasia were solely based on the information provided by the physicians in charge. Stroke etiology was determined by the same stroke neurologist according to the Trial of Org 10172 in Acute Stroke Treatment TOAST. 32 Data about the risk factor profile, clinical symptoms and syndromes, and the findings of etiological investigations were reviewed. The latter comprised extracranial and transcranial Doppler/duplex sonography (nϭ189), computed tomography scan (nϭ228), MRI with magnetic resonance angiogram (nϭ128), digital subtraction angiogram (nϭ11), 24-hour ECG Epidemiology of aphasia attributable to first ischemic stroke in Basle City. Flowchart summarizing data sources and composition of the study population.
(nϭ130), and echocardiography (nϭ162). High-risk or medium-risk sources for cardiac embolism had to be present for cardioembolic stroke etiology. Patients with 2 possible stroke pathomechanisms (eg, high-grade carotid stenosis and atrial fibrillation) were classified as having undetermined stroke etiology, as were those with incomplete workup. 32 Patients with missing data were excluded from this part of the study (ie, comparison between stroke etiology and presence versus absence of aphasia). These were 23 of 269 patients (8.6%) of the entire population or 11 of 80 (13.8%) of the aphasic subgroup, respectively.
Aphasic Versus Nonaphasic Stroke Patients
We compared aphasic with nonaphasic stroke patients in respect of stroke etiology, demographic characteristics, stroke risk factors according to criteria used by other epidemiological studies, 33 type of stroke care provider (ie, stroke unit, other hospital, or primary care physician), and stroke onset-assessment interval. The latter was defined as the time delay between first stroke symptoms (or the time the patient was last seen without symptoms if exact onset was unknown) and the clinical assessment of stroke and aphasia. In addition, we compared the rates of thrombolysis between both groups based on the Basle thrombolysis databank, in which data of all thrombolyzed stroke patients have been prospectively ascertained since 1997.
Data Analysis
All ages were included in the analysis. Overall, gender-and age-specific incidence rates of aphasia attributable to FEIS were calculated per 100 000 population with 95% CI. In addition, a direct standardization to the European standard population was performed. 25 Furthermore, we assessed the frequency of aphasia in FEIS patients across ages and gender. Bivariate analysis was performed with the 2 test for dichotomous/polytomous variables. Analyses of continuous variables were done with the t test. The associations between aphasia and age (unadjusted and adjusted for atrial fibrillation), aphasia and gender (adjusted for age), aphasia and smoking (adjusted for age), and aphasia and thrombolysis (controlling for stroke onsetassessment interval and age) were examined using logistic regres- Stroke onset-assessment interval was defined as time interval between stroke onset (or time patient was last seen without symptoms) until clinical stroke assessment took place. In 5 patients (1.9%), data were missing. They were excluded from this part of the study. †In 23 (8.6%) patients, data about risk factor profile and etiological workup were missing. They were excluded from this part of the study; ‡stroke etiology according to TOAST; 32 $this category includes dissection, vasculitis, and other uncommon causes of stroke; ‫ء‬including patients with Ն2 etiologies.
Adjusted for atrial fibrillation£, age¢, or stroke onset-assessment interval°. 
Results

Study Population
Among 269 FEIS patients, 80 patients had aphasia, yielding an overall 30% (95% CI, 24% to 36%) prevalence of aphasia in FEIS. Clinical stroke assessment took place after a median of 20 hours (range 30 minutes to 6 weeks). The 25/50/75 percentiles of the stroke onset-assessment interval were 5/20/60 hours. Aphasic FEIS patients had a shorter median onset-assessment interval (13 hours) than their nonaphasic peers (22 hours). Atrial fibrillation was more common in aphasic (42%) than in nonaphasic (23%) FEIS patients, yielding an OR of 2.41 (95% CI, 1.33 to 4.35). Other stroke risk factors and the type of stroke care did not differ significantly between both groups ( Table 1) .
Incidence of Aphasia Attributable to FEIS
The overall crude incidence rate of aphasia attributable to FEIS amounted to 43 per 100 000 population (95% CI, 33 to 52; Table  2 ). The age-specific incidence rates of FEIS-related aphasia increased steeply with age from 5 per 100 000 population among the Ͻ65 years of age group to 441 for those Ն85 years of age. After adjustment for age to the European standard population, the overall incidence rate was 21 per 100 000 population (95% CI, 13 to 28). It was similar in females (22; 95% CI, 15 to 29) and males (20; 95% CI, 12 to 28).
Effect of Age and Gender
Aphasic FEIS patients were older than their nonaphasic peers (mean age 80 years versus 75 years; Pϭ0.002). The risk of experiencing aphasia resulting from FEIS increased by 4% (95% CI, 1% to 7%) and after controlling for atrial fibrillation by 3% (95% CI, 1% to 7%) with each year of stroke patient age. Frequency of aphasia among FEIS patients increased from 15% (95% CI, 5% to 26%) in patients Ͻ65 years of age to 43% (95% CI, 30% to 56%) among those Ն85 years of age (Pϭ0.002; 
Aphasia Severity and Fluency Stratified by Gender and Age
Aphasia was mild in 35 (44%), moderate in 24 (30%), and severe in 21 (26%) patients, respectively. Aphasia was fluent in 23 (29%) and nonfluent in 48 (60%) of the patients (in 9, or 11%, patients fluency ratings were unclassified or missing). There were no statistically significant differences between females and males with regard to aphasia severity (Pϭ0.31) and fluency (Pϭ0.32). The same holds true for the relationship between age and aphasia severity (Pϭ0.26) as well as fluency (Pϭ0.86).
Stroke Etiology
Cardioembolism was more frequent in aphasic than in nonaphasic FEIS patients (OR, 1.85; 95% CI, 1.07 to 3.20; Pϭ0.03). In aphasic FEIS patients, cardioembolism was the underlying stroke etiology in about one half of the patients (48%), and it represents the main determined stroke etiology for this cohort. In turn, small vessel occlusion accounted for 22% of the strokes among nonaphasic FEIS patients but was not present in the aphasic FEIS cohort (PϽ0.001; Table 1 ). 
Discussion
This prospective, population-based study about the epidemiology of aphasia attributable to FEIS showed the main findings: 33 to 52 of 100 000 inhabitants are affected per year, and advancing age and cardioembolism are associated with an increased risk for aphasia. The risk of aphasia increased by 1% to 7% per each year of age of stroke patients. Every seventh FEIS patient Ͻ65 years of age had aphasia, whereas the proportion nearly tripled for subjects Ն85 years of age. So far, an age-dependent increase in the occurrence of aphasia has been noticed only in one 10 among several aphasia studies without such an association. 6, 9, 17 However, our finding is corroborated by data from multicenter, hospital-based stroke registries in which aphasia was significantly more frequent among older than among younger stroke patients. 35, 36 Female gender was not an independent risk factor for aphasia resulting from FEIS. This finding is in line to the majority of aphasia studies 13, 20, 37 but is in contrast to 2 stroke databank studies. 17, 38 Neither gender nor age had an influence on severity or fluency of aphasia, which is in line with the majority of aphasia studies. 6,20 -22 Some studies had suggested that nonfluent aphasia is more common in men 9 and that severity 18, 19 and fluency of aphasia 11, 13 increase with advancing age.
Cardioembolism was present in nearly one half of the aphasic FEIS patients and represents the most important etiology in the aphasic cohort. The impact of atrial fibrillation as major contributor to cardioembolic stroke increases steadily with age. 39 The age gradient was also noticed for the likelihood of aphasia as stroke symptom in the current study and may suggest a causal relationship. Thus, cardioembolism may disproportionately frequently cause aphasia. For Wernicke's aphasia, such a relationship was indeed shown. 23 Our results indicate that this association may be extended to ischemic aphasia per se.
Aphasic stroke patients sought medical help earlier than nonaphasic patients, possibly because stroke diagnosis was easier or loss of speech caused more fear than other symptoms in the patients. After controlling for the (shorter) stroke onset-assessment interval, still, the presence of aphasia was associated with a higher likelihood of thrombolysis. However, the small sample size and the wide 95% CI urge toward a cautious interpretation of this observation, which might have occurred by chance. It has been reported recently that patients with right-hemisphere strokes were less likely to receive intravenous thrombolysis than those with lefthemisphere strokes. 40 Thus, both observations might support the hypothesis that left-hemispheric symptoms increase the odds for thrombolysis.
As strengths, the present study made incidence estimates based on hospitalized as well as nonhospitalized aphasia patients from a well-defined catchment area. Furthermore, multiple overlapping sources of information were used to ascertain preferably all FEIS regardless of where acute stroke care took place. Such an approach is recommended for epidemiological stroke studies 16 but is novel in aphasia studies to the best of our knowledge.
A weakness of this approach is that the extent of language assessment and the level of expertise of the raters differed across the study population. Thus, the probability of falsepositive or false-negative aphasia diagnoses is likely to vary across the data sources. The highest rates of misdiagnosis are expected among nonhospitalized patients for whom aphasia diagnosis is solely based on the assessment of primary care physicians. This subgroup contributes to 4% of FEIS and to 9% of the aphasic FEIS patients, respectively, whereas Ͼ90% of the FEIS patients were evaluated by either an experienced neurologist with training and expertise in stroke and aphasia, by a speech therapist, or both. Exclusion of all patients exclusively assessed by primary care physicians would amount to an incidence rate of 39 (95% CI, 30 to 48), which is not substantially different from that of the entire population (43; 95% CI, 33 to 52). Thus, significant alterations of our results resulting from misclassification are unlikely. As another limitation, information about risk factor profile was obtained retrospectively, and etiological investigations were not done thoroughly in all patients. Therefore, the association between presence of aphasia and cardioembolism as underlying stroke etiology requires confirmation. As a caveat, we excluded patients with new aphasia resulting from recurrent stroke and those with aphasia caused by mechanisms other than ischemic stroke. Thus, our data must not be interpreted as an overall estimate of the incidence of aphasia per se.
